Cargando…

Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?

Detalles Bibliográficos
Autores principales:	Azfr Ali, Ruba Saleh, Jalal, Zahraa, Paudyal, Vibhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311327/ https://www.ncbi.nlm.nih.gov/pubmed/34396043 http://dx.doi.org/10.1136/gpsych-2021-100561

Ejemplares similares

Guideline adherence for cardiometabolic monitoring of patients prescribed antipsychotic medications in primary care: a retrospective observational study
por: Ali, Ruba Azfr, et al.
Publicado: (2023)

Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs: a systematic review
por: Ali, Ruba Azfr, et al.
Publicado: (2020)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Perioperative care in perforation peritonitis: Where do we stand?
por: Garg, Rakesh
Publicado: (2013)

Topical therapy of psoriasis: Where do we stand?
por: Thappa, DM, et al.
Publicado: (2017)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Surgical trials in India, where do we stand?
por: Khajanchi, M
Publicado: (2022)

Hyperbaric oxygen therapy promotes neurogenesis: where do we stand?
por: Mu, Jun, et al.
Publicado: (2011)

Immunosenescence and Cytomegalovirus: where do we stand after a decade?
por: Pawelec, Graham, et al.
Publicado: (2010)

Platelet Rich Plasma in Androgenic Alopecia: Where do we Stand?
por: Godse, Kiran
Publicado: (2014)

Commentary: Deep learning in retinopathy of prematurity: Where do we stand?
por: Sen, Parveen, et al.
Publicado: (2022)

Treatment of Diabetes in Bullous Pemphigoid Patients: Where Do We Stand?
por: Alexandre, Maria Inês, et al.
Publicado: (2023)

Calcium and Vitamin D in the Regulation of Energy Balance: Where Do We Stand?
por: Soares, Mario J., et al.
Publicado: (2014)

Risk stratification tools in prostate cancer, where do we stand?
por: Clinckaert, Andries, et al.
Publicado: (2021)

Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
por: Miller, Kathy D
Publicado: (2004)

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Commentary: Viral serology testing before cataract surgery: Where do we stand?
por: Nayak, Bhagabat, et al.
Publicado: (2022)

Where Do We Stand?
Publicado: (1891)

Intrauterine exposures, pregnancy estrogens and breast cancer risk: where do we currently stand?
por: Lagiou, Pagona
Publicado: (2006)

Commentary: Systemic versus imaging biomarkers for diabetic macular oedema – Where do we stand?
por: Rana, Vipin, et al.
Publicado: (2021)

Guidelines and evidence-based recommendations in anaesthesia: where do we stand?
por: Rong, Lisa Q., et al.
Publicado: (2022)

Health of Refugees and Migrants—Where Do We Stand and What Directions Should We Take?
por: Keidar, Osnat, et al.
Publicado: (2019)

Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
por: Choi, Jonggi, et al.
Publicado: (2016)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Sperm DNA fragmentation testing: where we stand in 2017
por: Tandon, Salil
Publicado: (2017)

Guidelines for alcohol consumption in the era of ‘no safe levels’ - where do we stand?
por: Pulido Valente, F
Publicado: (2023)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

The hazards and risks of inhaled poorly soluble particles – where do we stand after 30 years of research?
por: Borm, Paul J. A., et al.
Publicado: (2019)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Demoralization: Where it stands-and where we can take it: A bibliometric analysis
por: Zheng, Qingyong, et al.
Publicado: (2022)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Evidence-based guidelines for bleeding in trauma patients: where do we go from here?
por: Minei, Joseph P
Publicado: (2007)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Pixel Detectors ... where do we stand?
por: Wermes, Norbert
Publicado: (2019)

Laser accelerators : where do we stand
por: Lawson, J D
Publicado: (1985)

Renormalization schemes: where do we stand?
por: Ward, B F L
Publicado: (1990)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_54nl2qapecreipal5vilbq2fss